This bridge program will now allow Medicare beneficiaries access to GLP-1 medications for weight loss through a monthly subscription model, which raises important questions about who pays, how much it will cost, and whether the program can be sustained long term, Kevin Thompson, the CEO of 9i Capital Group and the host of the 9innings podcast, told Newsweek
Stoploss Coverage Stoploss coverage limits the amount that a plan sponsor has to pay in claims
[53] In two of these (NCT03954834 and NCT04039503), participants were randomly assigned to receive either tirzepatide or placebo injection weekly
Regulatory Context: Afamelanotide (marketed as Scenesse) is FDA-approved for the treatment of erythropoietic protoporphyria (EPP)
Oral versus injectable GLP-1 formulations Oral GLP-1 formulations like oral tirzepatide and oral semaglutide drops eliminate the injection site question entirely
Uterine fibroids, also called leiomyomas or myomas, are benign (noncancerous) tumors that grow within or on the surface of the uterus